Cytochrome-P450 enzymes and autoimmunity: Expansion of the relationship and introduction of free radicals as the link

Journal of Autoimmune Diseases

Volumn 6, Issue 1, 2009, Pages

  Namazi, M R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CYTOCHROME P450; FREE RADICAL; REACTIVE OXYGEN METABOLITE; XENOBIOTIC AGENT;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DRUG METABOLISM; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOPHYSIOLOGY;

EID: 68149181532     PISSN: None     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-6-4     Document Type: Article

References (23)

1. Molecular Mimicry of Human Cytochrome P450 by Hepatitis C Virus at the Level of Cytotoxic T Cell Recognition. AR Kammer SH van der Burg B Grabscheid IP Hunziker KM Kwappenberg J Reichen CJ Melief A Cerny, J Exp Med. 1999 190 2 169 176 10432280 10.1084/jem.190.2.169 (Pubitemid 29354910)
2. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. O Winqvist J Gustafsson F Rorsman FA Karlsson O Kämpe, J Clin Invest. 1993 92 5 2377 2385 8227354 10.1172/JCI116843
3. Cytochrome P-450 Enzymes as Targets for Chemoprevention against Chemical Carcinogenesis and Toxicity: Opportunities and Limitations. CH Yang TJ Smith J-Y Hong, Cancer Res. 1994 54 7 Suppl 1982S 1986S 8137324
4. Drug metabolism. FJ Gonzalez RH Tukey, Goodman & Gilman's The Pharmacologic Basis of Therapeutics New York: McGraw Hill, Brunton LL, Lazo JS, Parker KL, 11 2006 71 91
5. Cytochrome P450 and xenobiotic receptor humanized Mice. FG Gonzalez A-M Yu, Annu Rev Pharmacol Toxicol. 2006 46 41 64 16402898 10.1146/annurev.pharmtox. 45.120403.100007 (Pubitemid 43271183)
6. Oxidative stress in the pathogenesis of skin disease. DR Bickers M Athar, J Invest Dermatol. 2006 126 12 2565 2575 10.1038/sj.jid.5700340 17108903 (Pubitemid 44764040)
7. Oxidative stress and experimental carcinogenesis. M Athar, Indian J Exp Biol 2002 40 6 656 67 12587714
8. Free radical theory of autoimmunity. S Kannan, Theor Biol Med Model 2006 3 22 16759382 10.1186/1742-4682-3-22 (Pubitemid 44065638)
9. Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? MR Namazi, Pigment Cell Res. 2007 20 5 360 363 17850509
10. Oxidatively modified autoantigens in autoimmune diseases. BT Kurien K Hensley M Bachmann RH Scofield, Free Radic Biol Med. 2006 41 4 549 556 10.1016/j.freeradbiomed.2006.05.020 16863987 (Pubitemid 44080517)
11. Detection of rheumatoid factors in sera and biopsy lesions of vitiligo patients. F Vahedi Darmian S Joubeh M Doroudchi B Abdollahi A Ghaderi, Iran J Immunol 2004 1 1 48 55
12. ROS as signalling molecules in T cells-evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. HR Grifiths, Redox Rep. 2005 10 6 273 280 10.1179/135100005X83680 16438798 (Pubitemid 44111122)
13. Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. G Chaudhri NH Hunt IA Clark R Ceredig, Cell Immunol. 1998 115 1 204 213 10.1016/0008-8749(88)90174-8
14. Antioxidant activity, lipid peroxidation, and skin diseases. What's new? S Briganti M Picardo, J Eur Acad Dermatol Venereol. 2003 17 6 663 669 10.1046/j.1468-3083.2003.00751.x 14761133 (Pubitemid 37428088)
15. Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skindendritic cell line. TJ Matos CB Duarte M Goncalo MC Lopes, Immunol Cell Biol. 2005 83 6 607 614 10.1111/j.1440-1711. 2005.01378.x 16266312 (Pubitemid 43083092)
16. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. NS Chandel WC Trzyna DS McClintock PT Schumacker, J Immunol. 2000 165 2 1013 1021 10878378
17. Transcription factor NF-kappaB: a sensor for smoke and stress signals. KS Ahn BB Aggarwal, Ann N Y Acad Sci. 2005 1056 218 233 10.1196/annals.1352.026 16387690 (Pubitemid 43030980)
18. Oxidatively modified autoantigens in autoimmune diseases. BT Kurien K Hensley M Bachmann RH Scofield, Free Radic Biol Med 2006 41 4 549 556 10.1016/j.freeradbiomed.2006.05.020 16863987 (Pubitemid 44080517)
19. Role of reactive oxygen species (ROS) in apoptosis induction. HU Simon A Haj-Yehia F Levi-Schaffer, Apoptosis 2000 5 5 415 8 10.1023/A:1009616228304 11256882 (Pubitemid 32162623)
20. Cell death and autoimmunity. CA Casiano FJ Pacheco, Autoantibodies and Autoimmunity Weinheim: Wiley-VCH Verlag, Pollard KM, 2006 107 137
21. Vitiligo puzzle: the pieces fall in place. W Westerhof M d'Ischia, Pigment Cell Res. 2007 20 5 345 359 17850508
22. The role of cytochrome p-450 enzymes in endogenous signaling pathways and environmental carcinogenesis. DW Neber PT Dalton, Nature Rev Cancer. 2006 6 12 947 960 10.1038/nrc2015 (Pubitemid 44862679)
23. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. M Abu-Shakra D Buskila M Ehrenfeld K Conrad Y Shoenfeld, Ann Rheum Dis. 2001 60 5 433 440 11302861 10.1136/ard.60.5.433 (Pubitemid 32417413)